Biology subjects

Lenaerts, T.

Publications and source records attributed to Lenaerts, T..

5 recordsLinked to original sources

bioRxiv2022

RedRibbon: A new rank-rank hypergeometric overlap pipeline to compare gene and transcript expression signatures

MotivationHigh throughput omics technologies have generated a wealth of large protein, gene and transcript datasets that have exacerbated the need for new methods to analyse and compare big datasets. Rank-rank hypergeometric overlap is an important threshold-free method to combine and visualize two ranked lists of P-values or fold-changes, usually from differential gene expression analyses. Here, we introduce a new rank-rank hypergeometric overlap-based method aimed at both gene level and alternative splicing analyses at transcript or exon level, hitherto unreachable as transcript numbers are an order of magnitude larger than gene numbers. ResultsWe tested the tool on synthetic and real datasets at gene and transcript levels to detect correlation and anti-correlation patterns and found it to be fast and accurate, even on very large datasets thanks to an evolutionary algorithm based minimal P-value search. The tool comes with a ready-to-use permutation scheme allowing the computation of adjusted P-values at low time cost. Additionally, the package is a drop-in replacement to previous packages as a compatibility mode is included, allowing to re-run older studies with close to no change to existing pipelines. RedRibbon holds the promise to accurately extricate detailed information from large analyses. AvailabilityRNA-sequencing datasets are available through the Gene Expression Omnibus (GEO) portal with accession numbers GSE159984, GSE133218, GSE137136, GSE98485, GSE148058 and GSE108413. The C libraries and R package code are open to the community with a permissive licence (GPL3) and available for download from GitHub https://github.com/antpiron/ale, https://github.com/antpiron/cRedRibbon and https://github.com/antpiron/RedRibbon. Contactanthony.piron@ulb.be

bioinformatics↗

bioRxiv2020

Multistage feedback driven compartmental dynamics of hematopoiesis

Human hematopoiesis is surprisingly resilient to disruptions, providing suitable responses to severe bleeding, long lasting immune activation, and even bone marrow transplants. Still, many blood disorders exist which push the system past its natural plasticity, resulting in abnormalities in the circulating blood. While proper treatment of such diseases can benefit from understanding the underlying cell dynamics, these are non-trivial to predict due to the hematopoietic systems hierarchical nature and complex feedback networks. To characterize the dynamics following different types of perturbations we investigate a model representing hematopoiesis as a sequence of compartments covering all maturation stages - from stem to mature cells - where feedback regulates cell production to ongoing necessities. We find that a stable response to perturbations requires the simultaneous adaptation of cell differentiation and self-renewal rates, and show that under conditions of continuous disruption - as found in chronic hemolytic states - compartment cell numbers evolve to novel stable states.

systems biology↗

bioRxiv2019

Predicting disease-causing variant combinations

Notwithstanding important advances in the context of single-variant pathogenicity identification, novel breakthroughs in discerning the origins of many rare diseases require methods able to identify more complex genetic models. We present here the Variant Combinations Pathogenicity Predictor (VarCoPP), a machine-learning approach that identifies pathogenic variant combinations in gene pairs (bi-locus variant combinations). We show that the results produced by this method are highly accurate and precise, an efficacy that is endorsed when validating the method on recently published independent disease-causing data. Confidence labels of 95% and 99% are identified, representing the probability of a bi-locus combination being a true pathogenic result, providing geneticists with rational markers to evaluate the most relevant pathogenic combinations and limit the search space and time. Finally, VarCoPP has been designed to act as an interpretable method that can provide explanations on why a bi-locus combination is predicted as pathogenic and which biological information is important for that prediction. This work provides an important new step towards the genetic understanding of rare diseases, paving the way to new clinical knowledge and improved patient care.

bioinformatics↗

bioRxiv2017

DiGeST: Distributed Computing for Scalable Gene and Variant Ranking with Hadoop/Spark

BackgroundThe advent of next-generation sequencing technologies has opened new avenues for clinical genomics research. In particular, as sequencing costs continue to decrease, an ever-growing number of clinical genomics institutes now rely on DNA sequencing studies at varying scales - genome, exome, mendeliome - for uncovering disease-associated variants or genes, in both rare and non-rare diseases.\n\nA common methodology for identifying such variants or genes is to rely on genetic association studies (GAS), that test whether allele or genotype frequencies differ between two groups of individuals, usually diseased subjects and healthy controls. Current bioinformatics tools for performing GAS are designed to run on standalone machines, and do not scale well with the increasing size of study designs and the search for multi-locus genetic associations. More efficient distributed and scalable data analysis solutions are needed to address this challenge.\n\nResultsWe developed a Big Data solution stack for distributing computations in genetic association studies, that address both single and multi-locus associations. The proposed stack, called DiGeST (Distributed Gene/variant Scoring Tool) is divided in two main components: a Hadoop/Spark high-performance computing back-end for efficient data storage and distributed computing, and a Web front-end providing users with a rich set of options to filter, compare and explore exome data from different sample populations. Using exome data from the 1000 Genomes Project, we show that our distributed implementation smoothly scales with computing resources. We make the resulting software stack Open-Source, and provide virtualisation scripts to run the complete environment both on standalone machine or Hadoop-based cluster.\n\nConclusionsHadoop/Spark provides a powerful and well-suited distributed computing framework for genetic association studies. Our work illustrates the flexibility, ease of use and scalability of the framework, and more generally advocates for its wider adoption in bioinformatics pipelines.

bioinformatics↗

bioRxiv2016

An evolving cancer instigates clonally unrelated neighboring cells to form distant metastases.

Based on the clonal evolution theory of cancer formation, a single cell within a tissue gains a cancer-driving mutation and thus a growth advantage. From this expanded cellular mass, another cell gains a new mutation allowing this newly mutated cell to gain new competitive advantage and to expand in number (thus clonal expansion). Another clone then emerges. Eventually all required mutations are gained, and a cancer forms. Consequently, while a primary lesion may harbor divergent subclones, all the subclones within the primary cancer as well as all metastatic growths in secondary organs share at least the very first oncogenic mutation that initiates the primary cancer. However, by tracking genetically marked mammary epithelial cells that suffered the initiating oncogenic mutation--and their neighboring mammary cells that did not-in several mouse models of human breast cancer, we found that genetically unrelated mammary epithelial cells can be colluded by neighboring mutated cells to disseminate, and that they can even undergo de novo tumorigenic transformation and form distant metastases. Therefore, clonally unrelated epithelial cells may contribute to cancer progression and to the heterogeneity of the systemic disease. The non-linear cancer spread has important implications in cancer prevention, treatment, and therapeutic resistance.

cancer biology↗